In: Medical Aspects of Chemical and Biological Warfare, The Textbooks of Military Medicine
Nearly 12% of Americans have used GLP-1 weight loss drugs Nearly 12% of Americans have used GLP-1 drugs for weight loss, including about one-fifth of women aged 50 to 64, according to a new RAND report
Promising effects beyond weight loss Researchers are currently studying the effect of GLP-1s on a wide range of conditions beyond diabetes, obesity, and heart disease, including renal, hepatic, neurological, and substance-use disorders
A substantial volume of data indicates that an elevated HR is independently associated with increased cardiovascular morbidity and mortality in the general population, in subjects with cardiovascular diseases, and those with diabetes [13, 14, 38, 39]
The ORIGIN trial showed that insulin glargine neither increased nor decreased cardiovascular events compared to standard care
14(4): e006042